iCAD is a global leader in medical technology providing innovative cancer detection and therapy solutions that are expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
iCAD’s Breast Health Solutions suite includes several first-in-kind products that are clinically proven to support cancer detection while optimizing workflow and efficiency. ProFound AI®, which is available for 2D and 3D mammography, or digital breast tomosynthesis (DBT), is clinically proven to slash reading times for radiologists by more than half, while increasing sensitivity by 8% and reducing the rate of false positives and unnecessary recalls by 7%. iCAD’s portfolio of cancer detection software also includes PowerLook® Density Assessment, an automated breast density solution that is designed to standardize the assessment of breast density in 2D and 3D mammography, and ProFound AI™ Risk, the world’s first and only clinical decision support tool that provides an accurate two-year breast cancer risk estimation that is truly personalized for each woman, based only on a screening mammogram.
iCAD’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is FDA-cleared, CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body, including early-stage breast cancer, nonmelanoma skin cancers, gynecological cancers and brain tumors. It uses a miniaturized x-ray source to deliver a precise, concentrated dose of radiation directly to the tumor site while minimizing the risk of damage to healthy tissue in nearby areas of the body. IORT with the Xoft System allows radiation oncologists and surgeons to work together to deliver a full course of radiation treatment in one day, at the time of surgery, while the patient is under anesthesia. For the treatment of certain types of tumors, such as early-stage breast cancers or certain types of brain tumors, IORT with the Xoft System may allow appropriately selected patients to potentially replace weeks of post-operative external beam radiation therapy (EBRT) with a single fraction of radiation.
Through passionate ingenuity, iCAD delivers transformative innovations to precisely and effectively detect and treat cancer earlier, empowering clinicians to provide quality, cost-effective patient care.